Search Results 531-540 of 18786 for prostate cancer
With some special help from his doctors, Tommy. Archer outraced prostate cancer in order to be there. Here's Dennis Douda for the Mayo Clinic News. Network ...
... prostate cancer and acute nonlymphocytic leukemia (ANLL). It belongs to the group of medicines known as antineoplastics or cancer medicines. Mitoxantrone is ...
Prostate cancer · Rectal cancer · Rhabdomyosarcoma · Salivary gland tumors ... Stage 4 prostate cancer · Stomach cancer · Suspicious breast lumps · Testicular ...
As chemotherapy and radiation enable patients with breast, lung or prostate cancer or melanoma to live longer, metastatic disease may arise.
Mayo Clinic researchers identify drug resistance factors for advanced prostate cancer. Colette Gallagher. September 22, 2022. Regeneration after rare head and ...
... prostate healthcare since they are diagnosed with prostate cancer more than any other race or ethnicity. Participation eligibility. Participant eligibility ...
... cancers of the prostate, bladder, and kidney, primarily focusing on patients with high-risk prostate cancer and advanced renal cell carcinoma. His work in ...
... prostate tissue, while carrying a low risk of side effects. Benign prostatic hyperplasia is enlargement of the prostate gland that's not related to cancer.
Examples of tumor markers include prostate-specific antigen (PSA) for prostate cancer and cancer antigen (CA) 125 for ovarian cancer. Using a scope to ...
We treat blood cancers and tumors, childhood cancers and adult conditions, common cancers and rare subtypes. ... Prostate cancer. Back to top. R. Recurrent breast ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.